Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers

Experimental and Molecular Pathology

Volumn 89, Issue 2, 2010, Pages 140-148

  Aggarwal, Anshu ^a   Hunter, William J ^b   Aggarwal, Himanshu ^a   Silva, Edibaldo D ^b   Davey, Mary S ^b   Murphy, Richard F ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; LRF; POK; POKEMON; ZBTB7

Indexed keywords

LEUKEMIA LYMPHOMA RELATED FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; ZBTB7A PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG CARCINOMA; LYMPHOMA; MESOTHELIOMA; NEOPLASM; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYMOMA; BREAST; BREAST TUMOR; COMPARATIVE STUDY; GENETICS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; METABOLISM; NON SMALL CELL LUNG CANCER; PATHOLOGY;

BREAST; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPHOMA; NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77956444364     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.05.002     Document Type: Article

References (31)

1. Agrawal A., Yang J., Murphy R.F., Agrawal D.K. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer. Exp. Mol. Pathol. 2006, 81:115-122.
2. Bos R., van Diest P.J., van der Groep P., Greijer A.E., Hermsen M.A.J.A., Heijnen I., Meijer G.A., Baak J.P.A., Pinedo H.M., Wall E., Shvarts A. Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1 alpha (HIF-1alpha). Oncogene 2003, 22:8948-8951.
3. Chang C.C., Ye B.H., Chaganti R.S., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl Acad. Sci. USA 1996, 93:6947-6952.
4. Cui M., Xu H., Yang Y. Expression and clinical significance of Pokemon protein in breast cancer. J. Clin. Surg. (Chinese) 2007, 15:399-401.
5. Davies J.M., Hawe N., Kabaroswski J., Huan Q.H., Zhu J., Brand N.J., Leprince D., Dhordain P., Cook N., Morriss-Kay G., Zelenta A. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 1999, 18:365-375.
6. Dhordain P., Albagli O., Ansieau S., Koken M.H.M., Deweindt C., Quief S., Lantoine D., Leutz A., Kerckaert J., Leprince D. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homodimerization in vivo. Oncogene 1995, 11:2689-2697.
7. Dorjgochoo T., Deming S.L., Gao Y.T., Lu W., Zhang Y., Ruan Z., Zheng W., Shu X.O. History of benign breast disease and risk of breast cancer among women in China: a case-control study. Cancer Causes Control 2008, 19:819-828.
8. Dupont W.D., Page D.L., Parl F.F., Vnencak-Jones C.L., Plummer W.D. Long-term risk of breast cancer in women with fibroadenoma. N. Engl. J. Med. 1994, 331:10-15.
9. Felicetti F., Bottero L., Felli N., Mattia G., Labbaye C., Alvino E., Peschle C., Colombo M.P., Care A. Role of PLZF in melanoma progression. Oncogene 2004, 23:4567-4576.
10. Jeon B.N., Yoo J.Y., Choi W.I., Lee C.E., Yoong H.G., Hur M.W. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J. Biol. Chem. 2008, 283:33199-33210.
11. Ji Y., He X.S., Zhu X.F., Zhang R., Ou Z.H. Expression of pokemon in hepatocellular carcinoma tissue, adjacent and far tissue, hepatocirrhosis and normal liver tissue. Chin. J. Exp. Surg. 2007, 24:187-189.
12. Kanazawa N., Moriyama M., Onizuka T., Sugawara K., Mori S. Expression of Bcl-6 protein in normal skin and epidermal neoplasms. Pathol. Int. 1997, 47:600-607.
13. Kelly K.F., Daniel J.M. POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 2006, 16:578-587.
14. Kukita A., Kukita T., Ouchida M., Maeda H., Yatsuki H., Kohashi O. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 1999, 94:1987-1997.
15. Laudes M., Christodoulides C., Sewter C., Rochford J.J., Cosnidine R.V., Sethi J.K., Vidal-Puig A., O'Rahilly S. Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J. Biol. Chem. 2004, 279:11711-11718.
16. Laudes M., Bilkovski R., Oberhauser F., Droste A., Golmolka M., Leeser U., Udelhoven M., Krone W. Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4. J. Mol. Med. 2008, 86:597-608.
17. Lee D.K., Suh D., Edenberg H.J., Hur M.W. POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J. Biol. Chem. 2002, 277:26761-26768.
18. Lee D.K., Kang J.E., Park H.J., Kim M.H., Yim T.H., Kim J.M., Heo M.K., Kim K.Y., Kwon H.J., Hur M.W. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. J. Biol. Chem. 2005, 280:27783-27791.
19. Liu C.J., Prazak L., Fajardo M., Yu S., Tyagi N., Di Cesae P.E. Leukemia/lymphoma related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J. Biol. Chem. 2004, 279:47081-47091.
20. Logarajah S., Hunter P., Kramam M., Steele D., Lakhani S., Bobrow L., Venkitaramam A., Wagner S. BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene 2003, 22:5572-5578.
21. Maeda T., Hobbs R.M., Merghoub T., Guernah I., Zelent A., Cordon-Cardo C., Teruya-Feldstein J., Pandolfi P.P. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005, 433:278-285.
22. Maeda T., Hobbs R.M., Pandolfi P.P. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res. 2005, 65:8575-8578.
23. Maeda T., Merghoub T., Hobbs R.M., Dong L., Maeda M., Zakrzewski J., van der Brink M.R., Zelent A., Shigmatsu H., Akashi K., Teruya-Feldstein J., Cattoretti G., Pandolfi P.P. Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 2007, 316:860-866.
24. Morrison D.J., Pendergrast P.S., Stavropoulos P., Colmenares S.U., Kobayashi R., Hernandez N. FBI-1, a factor that binds to HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res. 1999, 27:1251-1262.
25. Pessler F., Hernandez N. Flexible DNA binding of the BTB/POZ-domain protein FBI-1. J. Biol. Chem. 2003, 278:29327-29335.
26. Roh H.E., Lee M.N., Jeon B.N., Choi W., Kim Y.J., Yu M.Y., Hur M.W. Regulation of pokemon 1 activity by sumoylation. Cell. Physiol. Biochem. 2007, 20:167-180.
27. Rovin R.A., Winn R. Pokemon expression in malignant glioma: an application of bioinformatics methods. Neurosurg. Focus 2005, 19:E8.
28. Schubot F.D., Tropea J.E., Waugh D.S. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem. Biophys. Res. Commun. 2006, 351:1-6.
29. Stogios P.J., Chen L., Prive G.G. Crystal stucture of the BTB domain from the LRF/ZBTB7 transcriptional regulator. Protein Sci. 2007, 16:336-342.
30. Ye B.H. BCL-6 in the pathogenesis of non-Hodgkin's lymphoma. Cancer Invest. 2000, 18. 356:365.
31. Zhao Z.H., Wang S.F., Yu L., Wang J., Chang H., Yan W., Zhang J., Fu K. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Lung Cancer 2008, 62:113-119.